When it comes to talking about the prospect of immunotherapy what’s possible with today’s technology and what’s possible with better technology are not the same. The approaches we have today with NK cells are relatively unsophisticated compared to what’s possible.
When it comes to talking about the prospect of immunotherapy what’s possible with today’s technology and what’s possible with better technology are not the same. The approaches we have today with NK cells are relatively unsophisticated compared to what’s possible.